{"cdcTestId":"2022-0053","testcaseName":"Dose #1 Pfizer Covid-19 vaccine Dose #2 Novavax Covid-19 vaccine","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test Type","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1992-09-21T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2021-08-22T20:00:00","dateUpdated":"2022-09-27T11:43:56.429","generalDescription":"This test case describes when an adult is administered Pfizer\u0027s Covid-19 vaccine as the first dose and Novavax\u0027s Covid-19 as a second dose that the doses are valid. Another dose should be forecast.","changedInVersion":"4.27","reasonForChange":"v4.27 Updated Forecast Dates to align with the current Interim Clinical Considerations (09/2/2022) for a new bivalent mRNA booster 8 weeks after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group."}